Title : CYP17 inhibitors in prostate cancer: latest evidence and clinical potential.

Pub. Date : 2016 Jul

PMID : 27482286






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 An inhibitor of cytochrome P450 17alpha-hydroxy/17,20-lyase (CYP17) enzymes, abiraterone acetate, has already been approved for men with mCRPC. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 An inhibitor of cytochrome P450 17alpha-hydroxy/17,20-lyase (CYP17) enzymes, abiraterone acetate, has already been approved for men with mCRPC. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens